Skip to content

Understanding the Diversity in Polycystic Ovarian Syndrome: A Comprehensive Study of Symptoms, Hormones, Body Composition, and Autonomic Nervous System Activity

Mapping Heterogeneity in Polycystic Ovarian Syndrome: Integrating Clinical, Endocrinological, Body Composition Analysis and Vagosympathetic Tone - A Prospective Case Control study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074375
Enrollment
120
Registered
2024-09-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: HRV in PCOS patients and its correlation with clinical sub-types of PCOS and Hormonal profile.: HRV in PCOS patients and its correlation with clinical subtypes of PCOS and Hormonal leve

Sponsors

All India Institute of Medical Sciences Rajkot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The control group will be recruited from following inclusion criteria: a. Women between age 18–45 years b. Normo-androgenic Women (Absence of hirsutism) c. With history of regular, ovulatory menstrual cycles d. Morphologically normal ovaries on ultrasound. (The diagnosis of PCOS will be based on 2003 Rotterdam ESHRE/ASRM PCOS Consensus Workshop Group diagnostic criteria.)

Exclusion criteria

Exclusion criteria: Exclusion criteria includes: a. Hyperandrogenism (Cushing’s syndrome (based on history taking and physical examination, Late-onset congenital adrenal hyperplasia (by estimating the serum levels of 17-hydroxyprogesterone). b. Pregnant and breastfeeding women c. Patient on medications (Medications for Diabetes, Hypo/Hyperthyroidism, Dyslipidaemia, Hyperprolactinemia) d. Chronic or acute pelvic infection (Within the previous 30 days), any other serious medical problem e. Hormonal contraception and/or Anti-androgen therapy (Within the previous 6 months) f. Patients not willing or able to give informed consent

Design outcomes

Primary

MeasureTime frame
vagosympathetic balance and HRV parameters in PCOS and Non PCOS patients.Timepoint: HRV will be done after confirmation PCOS by clinical examinations and Hormonal Profile, only once during the study after recruitment.

Secondary

MeasureTime frame
Corelation between different sub-types of PCOS with HRV & hormonal profilesTimepoint: At Baseline.

Countries

India

Contacts

Public ContactDr Medhavi Sharma

AIIMS Rajkot

dr.medhavisharma23@gmail.com8302268405

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026